177 related articles for article (PubMed ID: 7805018)
21. Adenovirus-mediated p53 gene therapy and paclitaxel have synergistic efficacy in models of human head and neck, ovarian, prostate, and breast cancer.
Nielsen LL; Lipari P; Dell J; Gurnani M; Hajian G
Clin Cancer Res; 1998 Apr; 4(4):835-46. PubMed ID: 9563876
[TBL] [Abstract][Full Text] [Related]
22. Endogenous p53 gene status predicts the response of human squamous cell carcinomas to wild-type p53.
St John LS; Sauter ER; Herlyn M; Litwin S; Adler-Storthz K
Cancer Gene Ther; 2000 May; 7(5):749-56. PubMed ID: 10830722
[TBL] [Abstract][Full Text] [Related]
23. Adenovirus-mediated expression of dominant negative c-myb induces apoptosis in head and neck cancer cells and inhibits tumor growth in animal model.
Kim SY; Yang YS; Hong KH; Jang KY; Chung MJ; Lee DY; Lee JC; Yi HK; Nam SY; Hwang PH
Oral Oncol; 2008 Apr; 44(4):383-92. PubMed ID: 17690006
[TBL] [Abstract][Full Text] [Related]
24. Adenovirus-mediated wild-type p53 gene transfer as a surgical adjuvant in advanced head and neck cancers.
Clayman GL; Frank DK; Bruso PA; Goepfert H
Clin Cancer Res; 1999 Jul; 5(7):1715-22. PubMed ID: 10430074
[TBL] [Abstract][Full Text] [Related]
25. [Recombinant adenovirus-p53 gene therapy combined with radiotherapy for head and neck squamous-cell carcinoma].
Zhang SW; Xiao SW; Liu CQ; Sun Y; Su X; Li DM; Xu G; Zhu GY; Xu B
Zhonghua Zhong Liu Za Zhi; 2005 Jul; 27(7):426-8. PubMed ID: 16188130
[TBL] [Abstract][Full Text] [Related]
26. Delivery of the p53 tumor suppressor gene into lung cancer cells by an adenovirus/DNA complex.
Nguyen DM; Wiehle SA; Koch PE; Branch C; Yen N; Roth JA; Cristiano RJ
Cancer Gene Ther; 1997; 4(3):191-8. PubMed ID: 9171938
[TBL] [Abstract][Full Text] [Related]
27. [Therapeutic potential of recombinant adenovirus expressing p53 in hepatocellular carcinoma cell lines].
Guo Y; Zeng Y; Wang K; Zhu X; Luo H; Zheng M; Li M; Chen J
Zhonghua Gan Zang Bing Za Zhi; 2001 Jul; 9 Suppl():43-5. PubMed ID: 11509137
[TBL] [Abstract][Full Text] [Related]
28. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts.
Nielsen LL; Dell J; Maxwell E; Armstrong L; Maneval D; Catino JJ
Cancer Gene Ther; 1997; 4(2):129-38. PubMed ID: 9080122
[TBL] [Abstract][Full Text] [Related]
29. Variability of adenovirus receptor density influences gene transfer efficiency and therapeutic response in head and neck cancer.
Li D; Duan L; Freimuth P; O'Malley BW
Clin Cancer Res; 1999 Dec; 5(12):4175-81. PubMed ID: 10632357
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of transfection rates on head and neck squamous cell cancer by a novel adenovirus: an in vivo and in vitro study.
Lalonde ES; Beyer G; Friedlander PL; Kolls JK
Head Neck; 2002 Dec; 24(12):1038-46. PubMed ID: 12454941
[TBL] [Abstract][Full Text] [Related]
31. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
Suominen E; Toivonen R; Grenman R; Savontaus M
J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
[TBL] [Abstract][Full Text] [Related]
32. Adenovirus-mediated p53 gene therapy: overview of preclinical studies and potential clinical applications.
Horowitz J
Curr Opin Mol Ther; 1999 Aug; 1(4):500-9. PubMed ID: 11713766
[TBL] [Abstract][Full Text] [Related]
33. Effects of p53 gene therapy in radiotherapy or thermotherapy of human head and neck squamous cell carcinoma cell lines.
Higuchi Y; Asaumi J; Murakami J; Matsuzaki H; Wakasa T; Inoue T; Shigehara H; Konouchi H; Hisatomi M; Kawasaki S; Hiraki Y; Kishi K
Oncol Rep; 2003; 10(3):671-7. PubMed ID: 12684642
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of p27KIP1 gene transfer on head and neck squamous cell carcinoma cell lines.
Koh TY; Park SW; Park KH; Lee SG; Seol JG; Lee DW; Lee CT; Heo DS; Kim KH; Sung MW
Head Neck; 2003 Jan; 25(1):44-9. PubMed ID: 12478543
[TBL] [Abstract][Full Text] [Related]
35. In vivo adenovirus-mediated p53 tumor suppressor gene therapy for colorectal cancer.
Spitz FR; Nguyen D; Skibber JM; Cusack J; Roth JA; Cristiano RJ
Anticancer Res; 1996; 16(6B):3415-22. PubMed ID: 9042200
[TBL] [Abstract][Full Text] [Related]
36. Adenoviral p53 gene therapy in squamous cell cancer of the head and neck region.
Edelman J; Edelman J; Nemunaitis J
Curr Opin Mol Ther; 2003 Dec; 5(6):611-7. PubMed ID: 14755887
[TBL] [Abstract][Full Text] [Related]
37. The current status of gene therapy.
Clayman GL
Semin Oncol; 2000 Aug; 27(4 Suppl 8):39-43. PubMed ID: 10952437
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of hypoxic cell radio-sensitizers in terms of radio-sensitizing and repair-inhibiting potential. Dependency on p53 status of tumor cells and the effects on intratumor quiescent cells.
Masunaga S; Uto Y; Nagasawa H; Hori H; Nagata K; Suzuki M; Kinashi Y; Ono K
Anticancer Res; 2006; 26(2A):1261-70. PubMed ID: 16619533
[TBL] [Abstract][Full Text] [Related]
39. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse.
Kim J; Hwang ES; Kim JS; You EH; Lee SH; Lee JH
Cancer Gene Ther; 1999; 6(2):172-8. PubMed ID: 10195884
[TBL] [Abstract][Full Text] [Related]
40. Loss of p53 expression correlates with metastatic phenotype and transcriptional profile in a new mouse model of head and neck cancer.
Ku TK; Nguyen DC; Karaman M; Gill P; Hacia JG; Crowe DL
Mol Cancer Res; 2007 Apr; 5(4):351-62. PubMed ID: 17426250
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
